Pharma Journalist -

Royal Philips which is a global leader in health technology claimed health economic results from DEFINE FLAIR clinical trial comparing cost-effectiveness between instant wave-free ratio…
Read More...

Abbott claimed new late-breaking Clinical Trial data from the MOMENTUM 3 clinical study which is the largest left ventricular assist device (LVAD) trial in the world to evaluate…
Read More...

The Janssen Pharmaceutical Companies of Johnson and Johnson announced results of new analysis exhibiting that INVOKANA remarkably lessened the risk of cardiovascular death or…
Read More...

Novartis announced an additional strategic alliance with Science 37, a leader in decentralized clinical trial technology and design, to initiate up to 10 new clinical trials over the…
Read More...

Tango Therapeutics which is a biotechnology company creating novel, targeted medicines for specific cancer subtypes claimed the addition of three experienced leaders with deep…
Read More...

Eyenuk which is a leading developer of advanced artificial intelligence enabled clinically supported solutions to identify diseases via retinal image analysis declared that it has…
Read More...

TherapeuticsMD which is an innovative women's healthcare company claimed the FDA's admission of NDA for TX-001HR. TX-001HR is the company’s investigational bio-identical hormone therapy…
Read More...

InVivo Therapeutics Holdings Corporation became recipient of supplemental Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) for a second…
Read More...

Tyber Medical which is a privately held company emphasizing on developing breakthrough medical devices for private label opportunities and facilitating  the science  of bioengineered…
Read More...

Ortho Clinical Diagnostics which is  a global leader of in vitro diagnostics asserted the launch of Ortho's VITROS Immunodiagnostic Products C-peptide Reagent Pack and Calibrators that…
Read More...